AI Summary & Key Takeaways
AI InsightBut, it is should to note, that 32,3% of patients were excluded from the group of drug therapy (6 - due to side effects, which required its cancellation, 5 - due to absence of preventive antiarrhythmic activity).
📌 3 Key Takeaways
Abstract
The author has carried out the comparison of radiofrequent ablation (on the base of remote results analysis) and long-term drug therapy in paroxysmal AV-tachycardias in patients with WPW-syndrome.It was revealed the effectiveness of close catheter radiofrequent ablation in paroxysmal AV-tachycardias in patients with WPW-syndrome. Positive results has been achieved in 93,7% of patients: paroxysms of arrhythmia has been disappeared, patients interrupted to take antiarrhythmic drug, that caused their life quality improve significantly.Uninterrupted use of propafenone (in condition of good endurance of the preparate) prevents of AV-tachycardia paroxysms in 85,7% of cases of WPW-syndrome. But, it is should to note, that 32,3% of patients were excluded from the group of drug therapy (6 - due to side effects, which required its cancellation, 5 - due to absence of preventive antiarrhythmic activity).
Özet
Yazar, Wolf-Parkinson-White (WPW) sendromu bulunan hastalarda görülen parosismal supraventriküler taşikardide (PSVT) radyofrekans ablasyon tedavisi ile uzun süreli ilaç tedavisini karşılaştırdı. WPW sendromlu hastalardaki PSVT de, radyofrekans (RF) ablasyonun etkili olduğu ortaya kondu. Hastaların %93.7 sinde başarılı sonuç alındı: Aritmi paroksismaları kayboldu, hastaların aldıkları antiaritmik ilaç kesildi ve böylece yaşam kaliteleri arttı. Propafenonun sürekli kullanılması ile WPW sendromlu hastaların %85.7 sinde PSVT atakları önlendi. Fakat yan etki nedeni ile hastaların %32.3 ü ilaç grubundan çıkarıldı (5'i antiaritmik etki görülmemesine bağlı idi).